J&J buys $1 billion Elan stake, gains Alzheimer’s R&D

July 2nd, 2009 by Benedictus | Posted under Finance | .

LONDON/BOSTON (Reuters) – Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire most of the rights to Elan’s portfolio of experimental drugs to treat Alzheimer’s disease.

Share This Post

Have any comments?

Rss Feed Tweeter button Facebook button Myspace button Delicious button Digg button